Journal of Registry Management Continuing Education Quiz—SPRING 2023

Abstract

After reading the educational posters and completing the quiz, participants will be able to:

• Understand the association between travel distance to an academic health system and overall survival for patients with HPV-associated cancers

• Describe how travel burden affects diagnosis, treatment, and quality of life for cancer patients

• Understand the demographic, socioeconomic, and clinical characteristics of patients within the study population.

1. According to the study, HPV-associated cancers were identified using ICD-O-3 codes. All are primary sites that were included EXCEPT which of the following ranges?

   1. C53.0–C53.39

   2. C60.0–C60.9

   3. C54.0–C54.9

   4. C51.0–C51.9

2. Select the correct exclusion criteria for patients from the study.

   1. Patients under the age of 16 years

   2. Patients classified as having distant disease

   3. Cancers classified as borderline

   4. Patients missing the date of diagnosis or last contact information

3. Travel distance was classified as what categorical variable?

   1. Short (<25 miles), intermediate (25-74.9 miles), and long (≥75 miles)

   2. Metropolitan (<25 miles), suburban (25–74.9 miles), and rural (≥75 miles)

   3. Short (<25 miles), intermediate (25–75 miles), and long (>75 miles)

   4. Central Oklahoma, Northeastern Oklahoma, and Southwestern Oklahoma

4. According to Table 1, the majority of the patient population were what ethnicity and age group?

   1. Hispanic or Latino, age 50–64 years

   2. Non-Hispanic or Latino, <50 years

   3. Hispanic or Latino, <50 years

   4. Non-Hispanic or Latino, age 50–64 years

5. Per Table 1, the majority of patients traveled what distance?

   1. ≥75 miles

   2. 25–74.9 miles

   3. <25 miles

   4. Zero, unable to travel

6. What is the most common HPV-associated cancer?

   1. Oropharyngeal

   2. Cervical

   3. Vulvar

   4. Anal

7. What factors led to poorer survival for patients traveling intermediate and longer distances?

   1. Issues with transportation

   2. Differences in treatment and treatment compliance

   3. Advanced cancer stage at diagnosis

   4. All the above

8. The study calculated travel distance using what method?

   1. Geocoded residential address in the registry at the time of cancer diagnosis

   2. Geocoded address of family member closest to the academic center where the patient was staying during length of treatment

   3. Geocoded residential address in the registry at the time of follow-up or after treatment

   4. Residential address per address locator

9. Per the study results, what percent of patients traveled a short distance to care?

   1. 22.1%

   2. 32.0%

   3. 45.9%

   4. 26.1%

10. What was one limitation to the study findings?

    1. High lost-to-follow-up rate

    2. Misclassification using patient addresses at diagnosis only

    3. Cancer registries routinely assess HPV status

    4. High incidence of distant disease at time of diagnosis